Renaming cytokines: MCP-1, major chemokine in pancreatitis

Gut

Volumn 54, Issue 12, 2005, Pages 1679-1681

  Marra, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

CELL DAMAGE; CYSTIC FIBROSIS; EXTRACELLULAR MATRIX; FIBROSIS; GENE DELETION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; NOTE; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; WOUND HEALING;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FIBROSIS; PANCREAS; PANCREATITIS, CHRONIC; RATS;

EID: 28144456008     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.068593     Document Type: Note

References (25)

1. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 2003;361:1447-55.
2. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002;2:106-15.
3. Daly C, Rollins BJ. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 2003;10:247-57.
4. Rollins BJ, Walz A, Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991;78:1112-16.
5. Grady T, Liang P, Ernst SA, et al. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-75.
6. Saurer L, Reber P, Schaffner T, et al. Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-67.
7. Inoue M, Ino Y, Gibo J, et al. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibulyltin dichloride in rats. Pancreas 2002;25:e64-70.
8. Zhao HF, Ito T, Gibo J, et al. Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut 2005;54:1759-67.
9. Sparmann G, Merkord J, Jaschke A, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997;112:1664-72.
10. Zhang Y, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 1995;15:4851-5.
11. Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer 2004;3:26.
12. Masamune A, Kikuta K, Satoh M, et al. Ligands of peroxisome proliferator-activated receptor-block activation of pancreatic stellate cells. J Biol Chem 2002;277:141-7.
13. Gharaee-Kermani M, Denholm EM, et al. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996;271:17779-84.
14. Marra F, Romanelli RG, Giannini C, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999;29:140-8.
15. Schecter AD, Berman AB, Yi L, et al. MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J Leukoc Biol 2004;75:1079-85.
16. Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998;152:423-30.
17. Bonacchi A, Petrai I, DeFranco RMS, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-76.
18. Paavola CD, Hemmerich S, Grunberger D, et al. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem 1998;273:33157-65.
19. Boring L, Gosling J, Chensue SW, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-61.
20. Gu L, Tseng S, Horner RM, et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000;404:407-11.
21. Wynn TA. Fibrotic disease and the T(H)1 /T(H)2 paradigm. Nat Rev Immunol 2004;4:583-94.
22. Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004;14:149-54.
23. Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1 -dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003;93:980-9.
24. Onuffer JJ, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci 2002;23:459-67.
25. Papachristou GI, Sass DA, Avula H, et al. Is the monocyte chemotactic protein-1 -2518G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005;3:475-81.